Markets:

Overview

News

Currencies

International

Treasuries

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

8.137 -0.133 (-1.61%)

Delayed Quote Updated: 10:08 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harvard Bioscience, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Earnings Preview: Harvard Bioscience ↗

March 08, 2023

Via Benzinga

Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET

February 28, 2023

From Harvard Bioscience, Inc.

Via GlobeNewswire

10 Stocks Under $10 for 2023 ↗

January 03, 2023

In 2023, the only certainty will be uncertainty. Investors should keep their portfolios flexible with these stocks under $10.

Via InvestorPlace

Harvard Bioscience Announces CFO Transition

December 12, 2022

From Harvard Bioscience, Inc.

Via GlobeNewswire

Harvard Bioscience Announces Third Quarter 2022 Financial Results

November 08, 2022

“Fighting through challenging times while building the company and new technologies for the future.”

From Harvard Bioscience, Inc.

Via GlobeNewswire

Earnings Preview: Harvard Bioscience ↗

November 07, 2022

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that Harvard...

Via Benzinga

Harvard Bioscience Schedules Third Quarter 2022 Earnings Conference Call for November 8, 2022 at 4:30 PM ET

November 02, 2022

From Harvard Bioscience, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 22, 2022

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

Via Benzinga

$92 Million Bet On This Penny Stock? Also Check Out Other 3 Stocks Under $5 Insiders Are Buying ↗

August 19, 2022

U.S. initial jobless claims dropped by 2,000 to 250,000 the week ended August 13th. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 12, 2022

On Friday, 39 companies reached new 52-week lows.

Via Benzinga

Harvard Bioscience Schedules Second Quarter 2022 Earnings Conference Call for August 4, 2022 at 8:00 AM ET

July 26, 2022

From Harvard Bioscience, Inc.

Via GlobeNewswire

Looking Into Harvard Bioscience's Return On Capital Employed ↗

May 19, 2022

Harvard Bioscience (NASDAQ:HBIO) brought in sales totaling $28.78 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 815.92%, resulting in a loss of $6.88...

Via Benzinga

81 Biggest Movers From Yesterday ↗

May 05, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 04, 2022

Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after...

Via Benzinga

Recap: Harvard Bioscience Q1 Earnings ↗

May 04, 2022

Harvard Bioscience (NASDAQ:HBIO) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout ↗

March 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Moderna Announces 4 Initiatives To Advance mRNA Vaccines As Preventative...

Via Benzinga

Harvard Bioscience: Q4 Earnings Insights ↗

March 08, 2022

Harvard Bioscience (NASDAQ:HBIO) reported its Q4 earnings results on Tuesday, March 8, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Earnings Scheduled For March 8, 2022 ↗

March 08, 2022

Companies Reporting Before The Bell • Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million. •...

Via Benzinga

Earnings Preview: Harvard Bioscience ↗

March 07, 2022

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Outlook For Harvard Bioscience ↗

March 07, 2022

Harvard Bioscience (NASDAQ:HBIO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg ↗

March 06, 2022

Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...

Via Benzinga

The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗

August 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts ↗

July 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

Stocks That Hit 52-Week Highs On Wednesday ↗

June 30, 2021

This morning 132 companies reached new 52-week highs. Noteworthy Mentions: The largest company by market cap to break to a new 52-week high was NVIDIA (NASDAQ:NVDA...

Via Benzinga

The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs ↗

June 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 29) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

5 Stocks with Solid Track Records at Attractive Prices ↗

June 05, 2021

You could become rich, but there’s an equal chance that you’ll lose whatever you have.

Via Talk Markets

Jim Cramer Gives His Opinion On Riot Blockchain, Viacom And More ↗

May 19, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said Harvard Bioscience, Inc. (NASDAQ: HBIO) had a good quarter and it's a decent spec. The whole pipeline...

Via Benzinga

Stocks That Hit 52-Week Highs On Tuesday ↗

June 29, 2021

Tuesday's morning session saw 105 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high was...

Via Benzinga

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Harvard Bioscience, Inc. - Common Stock (NQ:HBIO)

All News about Harvard Bioscience, Inc. - Common Stock

Starting at /week.